Table 2 |
|||||||||||||
|
Use of antithrombotic drugs, statins and beta-blockers among Finnish CHD-patients in 2001. |
|||||||||||||
| MEN |
All three |
Antithrombotic drugs |
Beta-blockers |
Statins |
|||||||||
| OR |
95% CI |
p value |
OR |
95% CI |
p = |
OR |
95% CI |
p value |
OR |
95% CI |
p value |
||
|
|
|||||||||||||
| Age |
45–54 |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| 55–64 |
0.80 |
0.58 – 1.11 |
0.83 |
0.40 – 1.72 |
0.71 |
0.45 – 1.13 |
0.87 |
0.62 – 1.23 |
|||||
| 65–74 |
0.57 |
0.41 – 0.79 |
<0.001 |
0.59 |
0.30 – 1.18 |
ns |
0.59 |
0.37 – 0.93 |
ns |
0.57 |
0.41 – 0.80 |
<0.001 |
|
| Income |
highest |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| third |
intermed |
0.77 |
0.58 – 1.01 |
1.16 |
0.65 – 2.06 |
1.05 |
0.74 – 1.50 |
0.68 |
0.51 – 0.90 |
||||
| lowest |
0.81 |
0.60 – 1.08 |
ns |
0.73 |
0.42 – 1.29 |
ns |
1.00 |
0.68 – 1.45 |
ns |
0.64 |
0.47 – 0.87 |
<0.01 |
|
| AMI |
no |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| yes |
1.34 |
1.08 – 1.67 |
<0.01 |
1.89 |
1.17 – 3.04 |
<0.01 |
1.45 |
1.09 – 1.95 |
<0.05 |
1.26 |
1.01 – 1.58 |
<0.05 |
|
| Use of |
less |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| nitrates |
≥ 1/week |
1.09 |
0.80 – 1.48 |
ns |
0.91 |
0.50 – 1.64 |
ns |
1.05 |
0.70 – 1.57 |
ns |
1.00 |
0.73 – 1.38 |
ns |
| Chest pain |
no |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| yes |
1.00 |
0.80 – 1.25 |
ns |
0.85 |
0.54 – 1.33 |
ns |
1.35 |
1.01 – 1.80 |
<0.05 |
0.88 |
0.70 – 1.11 |
ns |
|
| Diabetes |
no |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| yes |
0.95 |
0.69 – 1.29 |
ns |
1.48 |
0.74 – 2.94 |
ns |
1.56 |
1.00 – 2.44 |
ns |
0.83 |
0.61 – 1.14 |
ns |
|
| Heart |
no |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| failure |
yes |
0.89 |
0.69 – 1.16 |
ns |
0.85 |
0.52 – 1.39 |
ns |
0.97 |
0.69 – 1.36 |
ns |
0.81 |
0.62 – 1.06 |
ns |
| Revasc. |
no |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| yes |
2.26 |
1.81 – 2.82 |
<0.0001 |
2.57 |
1.60 – 4.13 |
0.0001 |
1.27 |
0.96 – 1.68 |
ns |
2.48 |
1.97 – 3.13 |
<0.0001 |
|
| WOMEN |
All three |
Antithrombotic drugs |
Beta-blockers |
Statins |
|||||||||
| OR |
95% CI |
p value |
OR |
95% CI |
p value |
OR |
95% CI |
p value |
OR |
95% CI |
p value |
||
| Age |
45–54 |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| 55–64 |
1.07 |
0.68 – 1.67 |
1.17 |
0.61 – 2.23 |
1.18 |
0.69 – 2.02 |
1.11 |
0.71 – 1.74 |
|||||
| 65–74 |
1.31 |
0.86 – 2.01 |
ns |
1.58 |
0.85 – 2.95 |
ns |
1.31 |
0.78 – 2.18 |
ns |
1.46 |
0.95 – 2.23 |
<0.01 |
|
| Income |
highest |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| third |
intermed |
1.14 |
0.83 – 1.55 |
0.94 |
0.58 – 1.54 |
1.06 |
0.72 – 1.57 |
1.29 |
0.94 – 1.77 |
||||
| lowest |
1.05 |
0.78 – 1.42 |
ns |
0.95 |
0.59 – 1.54 |
ns |
1.01 |
0.70 – 1.47 |
ns |
1.18 |
0.88 – 1.60 |
ns |
|
| AMI |
no |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| yes |
1.51 |
1.16 – 1.97 |
<0.01 |
2.79 |
1.60 – 4.89 |
<0.001 |
1.51 |
1.06 – 2.15 |
<0.05 |
1.52 |
1.16 – 2.00 |
<0.01 |
|
| Use of |
less |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| nitrates |
≥ 1/week |
1.21 |
0.92 – 1.59 |
ns |
1.11 |
0.71 – 1.76 |
ns |
0.90 |
0.64 – 1.27 |
ns |
1.20 |
0.91 – 1.59 |
ns |
| Chest pain |
no |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| yes |
1.19 |
0.93 – 1.51 |
ns |
1.14 |
0.78 – 1.67 |
ns |
1.25 |
0.93 – 1.68 |
ns |
1.13 |
0.89 – 1.44 |
ns |
|
| Diabetes |
no |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| yes |
1.27 |
0.93 – 1.75 |
ns |
1.26 |
0.73 – 2.19 |
ns |
1.03 |
0.69 – 1.54 |
ns |
1.23 |
0.89 – 1.71 |
ns |
|
| Heart |
no |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| failure |
yes |
0.94 |
0.72 – 1.23 |
ns |
0.96 |
0.62 – 1.48 |
ns |
1.03 |
0.73 – 1.45 |
ns |
0.92 |
0.70 – 1.20 |
ns |
| Revasc. |
no |
1.00 |
1.00 |
1.00 |
1.00 |
||||||||
| yes |
3.92 |
2.99 – 5.15 |
<0.0001 |
5.55 |
2.84 – 10.8 |
<0.0001 |
2.16 |
1.50 – 3.11 |
<0.0001 |
3.96 |
2.95 – 5.33 |
<0.0001 |
|
|
|
|||||||||||||
|
Models for use of each drug controlling only for age, five-year age bands. Odds ratios (OR) and their 95% confidence intervals (CI) |
|||||||||||||
|
Manderbacka et al. International Journal for Equity in Health 2008 7:16 doi:10.1186/1475-9276-7-16 |
|||||||||||||
